Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study

Open access
Valenzano, Marina, Cibrario Bertolotti, Ivan, Valenzano, Adriano, Grassi, Giorgio · 2021 · BMJ Open Diabetes Research & Care

Abstract

Introduction: The availability of easily accessible continuous glucose monitoring (CGM) metrics can improve glycemic control in diabetes, and they may even become a viable alternative to hemoglobin A1c (HbA1c) laboratory tests in the next years. The REALISM-T1D study (REAl-Life glucoSe Monitoring in Type 1 Diabetes) was aimed at contributing, with real-world data, to a deeper understanding of these metrics, including the time in range (TIR)–HbA1c relationship, to facilitate their adoption by diabetologists in everyday practice. Research design and methods: 70 adults affected by type 1 diabetes were monitored for 1 year by means of either flash (FGM) or real-time (rtCGM) glucose monitoring devices. Follow-up visits were performed after 90, 180 and 365 days from baseline and percentage TIR 70–180 evaluated for the 90-day time period preceding each visit. HbA1c tests were also carried out in the same occasions and measured values paired with the corresponding TIR data. Results: A monovariate linear regression analysis confirms a strong correlation between TIR and HbA1c as found in previous studies, but leveraging more homogeneous data (n=146) collected in real-life conditions. Differences were determined between FGM and rtCGM devices in Pearson’s correlation (r FGM=0.703, r rtCGM=0.739), slope (β 1,FGM=−11.77, β 1,rtCGM=−10.74) and intercept (β 0,FGM=141.19, β 0,rtCGM=140.77) coefficients. Normality of residuals and homoscedasticity were successfully verified in both cases. Conclusions: Regression lines for two patient groups monitored through FGM and rtCGM devices, respectively, while confirming a linear relationship between TIR and A1c hemoglobin (A1C) in good accordance with previous studies, also show a statistically significant difference in the regression intercept, thus suggesting the need for different models tailored to device characteristics. The predictive power of A1C as a TIR estimator also deserves further investigations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2019-001045

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 OLS linear regression with 95% confidence and prediction intervals on the whole data set (n=146), compared with Vigersky and McMahon.17 β1=−12.06±1.86, p<0.001; β0=146.54±13.83, p<0.001; r2=0.53. HbA1c, hemoglobin A1c; OLS, ordinary least squares; TIR, time in range.
Figure 1 OLS linear regression with 95% confidence and prediction intervals on the whole data set (n=146), compared with Vigersky and McMahon.17 β1=−12.06±1.86, p<0.001; β0=146.54±13.83, p<0.001; r2=0.53. HbA1c, hemoglobin A1c; OLS, ordinary least squares; TIR, time in range.CC BY-NC · PubMed Central
Figure 2 Q-Q plot of normalized residuals versus a normal distribution (µ=0, σ2=1) (A), scatter plot of the residuals (B), and comparison between a linear and a quadratic OLS regression (C). HbA1c, hemoglobin A1c; LR, linear regression; OLS, ordinary least squares; Q-Q, quartile-quartile; TIR, time in range.
Figure 2 Q-Q plot of normalized residuals versus a normal distribution (µ=0, σ2=1) (A), scatter plot of the residuals (B), and comparison between a linear and a quadratic OLS regression (C). HbA1c, hemoglobin A1c; LR, linear regression; OLS, ordinary least squares; Q-Q, quartile-quartile; TIR, time in range.CC BY-NC · PubMed Central
Figure 3 Linear regressions performed separately on patient groups monitored with different device types (FGM or rtCGM) and different sampling periods (900 s or 300 s) compared with Vigersky and McMahon.17 (A) FGM group: β1=−11.77±2.73, p<0.001; β0=141.19±20.6, p<0.001; r2=0.49. (B) rtCGM group: β1=−10.74±2.4, p<0.001; β0=140.77±17.35, p<0.001; r2=0.55. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; rtCGM, real-time CGM; TIR, time in range.
Figure 3 Linear regressions performed separately on patient groups monitored with different device types (FGM or rtCGM) and different sampling periods (900 s or 300 s) compared with Vigersky and McMahon.17 (A) FGM group: β1=−11.77±2.73, p<0.001; β0=141.19±20.6, p<0.001; r2=0.49. (B) rtCGM group: β1=−10.74±2.4, p<0.001; β0=140.77±17.35, p<0.001; r2=0.55. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; rtCGM, real-time CGM; TIR, time in range.CC BY-NC · PubMed Central
Figure 4 Monovariate versus multivariate regression using a categorical variable c to indicate FGM or rtCGM devices. Categorical coefficient βc=−7.19±3.20, p<0.001. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; OLS, ordinary least squares; rtCGM, real-time CGM; TIR, time in range.
Figure 4 Monovariate versus multivariate regression using a categorical variable c to indicate FGM or rtCGM devices. Categorical coefficient βc=−7.19±3.20, p<0.001. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; OLS, ordinary least squares; rtCGM, real-time CGM; TIR, time in range.CC BY-NC · PubMed Central
Figure 5 Linear regressions performed separately at time points t=90 days, t=180 days and t=365 days using both FGM and rtCGM sensor data. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; rtCGM, real-time CGM; TIR, time in range.
Figure 5 Linear regressions performed separately at time points t=90 days, t=180 days and t=365 days using both FGM and rtCGM sensor data. CGM, continuous glucose monitoring; FGM, flash CGM; HbA1c, hemoglobin A1c; rtCGM, real-time CGM; TIR, time in range.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 34

Metadata

Authors
Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G.
Affiliations
  • University of Turin (IT)
  • Institute of Electronics, Information and Telecommunication Engineering, CNR IEIIT, Torino, Piemonte, Italy
  • Institute of Electronics, Computer and Telecommunication Engineering (IT)
  • Endocrinology, Ospedale Molinette, Torino, Piemonte, Italy
Corresponding author
Grassi, Giorgio
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2021-01
Volume
9
Issue
1
Pages
e001045
ISSN
2052-4897 (ISSN-L)
OpenAlex
W3123398944
Cited by
34
References
33
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 6
FWCI
5.22
Type
journal article
Language
en
Open access
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
time in range, HbA1c, type 1 diabetes, continuous glucose monitoring, flash glucose monitoring, real-time glucose monitoring, glycemic control
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-001045
The paper
Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G. (2021). Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-001045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.